Position in LLY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$5,434,617
+$1,578,022 QoQ
Shares Held
4,531
+8.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#1,652
of 4,605 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keystone Financial Group holds $28,513,517 across 12 Drug Manufacturers - General names. LLY ranks #2 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,287 | $12,009,479 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
4,531 | $5,434,617 | |
| 3 | ABBV |
AbbVie Inc.
|
14,346 | $3,610,027 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,960 | $2,564,860 | |
| 5 | PFE |
Pfizer Inc
|
80,610 | $1,941,088 | |
| 6 | AMGN |
Amgen Inc
|
2,034 | $736,552 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,142 | $523,300 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,578 | $494,264 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,434,617 | 4,531 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,856,595 | 4,193 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,839,831 | 3,573 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,855,146 | 3,742 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $4,718,914 | 56,871 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,662,733 | 3,224 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,480,436 | 3,213 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,251,626 | 4,799 | Shares | Sole | 2025-02-19 | |
| 2024-06-30 | $3,880,458 | 4,286 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $2,731,417 | 3,511 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,394,927 | 2,393 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,357,327 | 2,527 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $871,833 | 1,859 | Shares | Sole | 2023-08-07 | |
| 2022-12-31 | $569,978 | 1,558 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $452,043 | 1,398 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $452,625 | 1,396 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $404,068 | 1,411 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $385,326 | 1,395 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $304,754 | 1,319 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $302,736 | 1,319 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $246,228 | 1,318 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $245,493 | 1,454 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $235,351 | 1,590 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $211,463 | 1,288 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||